Clincosm LogoSign in Get a demo

recurrent breast cancer

Showing 26 - 50 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • F-18 16 alpha-fluoroestradiol
  • +4 more
  • Seattle, Washington
    University of Washington Medical Center
Feb 7, 2020

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, procedure, radiation, other)

Completed
Has Results
  • Male Breast Cancer
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jan 2, 2020

Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in Philadelphia

Completed
Has Results
  • Ductal Breast Carcinoma in Situ
  • +6 more
  • Behavioral dietary intervention
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2019

CNS Metastases, HER2-positive Breast Cancer, Male Breast Cancer Trial in Los Angeles (lapatinib ditosylate, everolimus,

Completed
  • Central Nervous System Metastases
  • +4 more
  • lapatinib ditosylate
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Nov 8, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Duarte, South Pasadena (vorinostat, ixabepilone,

Completed
  • Male Breast Cancer
  • +2 more
  • Duarte, California
  • +1 more
Nov 1, 2019

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Chicago (cabergoline)

Completed
Has Results
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • Chicago, Illinois
    Northwestern University
Sep 4, 2019

Recurrent Breast Cancer Trial in Guangzhou (Trastuzumab, NK immunotherapy)

Completed
  • Recurrent Breast Cancer
  • Guangzhou, Guangdong, China
    Fuda cancer institute in Fuda cancer hospital
Sep 10, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,

Completed
Has Results
  • Male Breast Cancer
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019

Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,

Terminated
  • Chemotherapeutic Agent Toxicity
  • +11 more
  • cryotherapy
  • +4 more
  • Chicago, Illinois
    Northwestern University
Aug 16, 2019

Breast Tumor, Breast Cancer, Cancer of the Breast Trial in Worldwide (nab-Paclitaxel, Carboplatin, Gemcitabine)

Completed
Has Results
  • Breast Tumor
  • +10 more
  • Chandler, Arizona
  • +139 more
Feb 19, 2019

Breast Cancer, Recurrent Breast Cancer, Stereotactic Body Radiotherapy Trial in Seoul (Surgical resection, Stereotactic body

Recruiting
  • Breast Cancer
  • +5 more
  • Surgical resection
  • +2 more
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital
Feb 12, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +5 more
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +2 more
  • Anchorage, Alaska
  • +16 more
Nov 6, 2018

Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer Trial in Bronx (fulvestrant,

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Oct 4, 2018

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer Trial in Tucson

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • therapeutic estradiol
  • +3 more
  • Tucson, Arizona
    University of Arizona Cancer Center
Sep 21, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago, Evanston (mifepristone, ,

Completed
  • Male Breast Cancer
  • +5 more
  • Chicago, Illinois
  • +1 more
Sep 10, 2018

Male Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer Trial in Chicago, Evanston (mifepristone,

Completed
  • Male Breast Cancer
  • +7 more
  • Chicago, Illinois
  • +1 more
Sep 10, 2018

Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)

Terminated
  • Cardiovascular Complications
  • +7 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 30, 2018

Estrogen Receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer Trial

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +6 more
  • Tucson, Arizona
    Arizona Cancer Center
Jul 23, 2018

Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in New Orleans, Winston-Salem (biological, drug, procedure)

Terminated
Has Results
  • Breast Cancer
  • +2 more
  • panitumumab
  • +4 more
  • New Orleans, Louisiana
  • +1 more
Jul 3, 2018

Cognitive/Functional Effects, Recurrent Breast Cancer, Stage IA Breast Cancer Trial in Winston-Salem (ultrasound imaging,

Completed
  • Cognitive/Functional Effects
  • +7 more
  • ultrasound imaging
  • +4 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in New York (ganetespib, paclitaxel, trastuzumab)

Completed
  • HER2-positive Breast Cancer
  • +6 more
  • New York, New York
  • +1 more
Jun 13, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Tampa (biological, drug, other)

Completed
Has Results
  • Male Breast Cancer
  • +3 more
  • adenovirus-p53 transduced dendritic cell (DC) vaccine
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 14, 2018

Male Breast Cancer, Recurrent Breast Cancer, Skin Metastases Trial in Seattle (drug, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Dec 7, 2017